Free Newsletter
Protein therapies could delay aging process
For the first time, scientists at Albert Einstein College of Medicine have been able to prevent the age-related decline of the liver--a process that could have significant implications for preventing a host of age-related ailments like Parkinson's and Alzheimer's. The researchers were able to prevent the accumulation of harmful proteins inside a liver, stopping the aging process in the organ. Their work highlights the potential of new therapies that boost protein clearance.
"Our study showed that functions can be maintained in older animals so long as damaged proteins continue to be efficiently removed-- strongly supporting the idea that protein buildup in cells plays an important role in aging itself," said Dr. Ana Maria Cuervo. "Even more important, these results show that it's possible to correct this protein 'logjam' that occurs in our cells as we get older, thereby perhaps helping us to enjoy healthier lives well into old age."
- read the AFP article
Related Articles:
Sirtris advances new therapies to combat aging
Buck Institute to tackle aging research with stem cell funds
Resveratrol potential fires interest in longevity drugs
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: